Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Murat

Showing results (221-230 of 263) with videos related to

Pageof 27
Sort By:
European Radiology|August 20, 2025
Applying large language model for automated quality scoring of radiology requisitions using a standardized criteriaRaşit Eren Büyüktoka, Murat Surucu, Pelin Berfin Erekli Derinkaya, et al.
Molecular and Clinical Oncology|December 2, 2015
Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumabSeyda Gündüz, Sema Sezgin Göksu, Deniz Arslan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 26, 2014
Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging systemDeniz Arslan, Hakan Bozcuk, Seyda Gunduz, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 11, 2018
Adding taxane to platin-5-fluorouracil combination does not improve survival rate in patients ≥ 65 years of age with advanced gastric cancer: A retrospective-multicenter studyMeral Gunaldi, Fatih Kose, Nebi Serkan Demirci, et al.
Future Oncology (London, England)|April 13, 2019
The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetateCem Onal, Ali Murat Sedef, Fatih Kose, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 1, 2019
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetateBerna Akkus Yildirim, Cem Onal, Fatih Kose, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 28, 2014
Risk factors for stage IV breast cancer at the time of presentation in TurkeyUmmugul Uyeturk, Ali Murat Tatli, Sebahat Gucuk, et al.
Medicina (Kaunas, Lithuania)|February 26, 2025
Comparison of Standard Neoadjuvant Therapy and Total Neoadjuvant Therapy in Terms of Effectiveness in Patients Diagnosed with Locally Advanced Rectal CancerAyberk Bayramgil, Ahmet Bilici, Ali Murat Tatlı, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) StudyZiya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Medicina (Kaunas, Lithuania)|January 28, 2026
The Impact of Concurrent Proton Pump Inhibitors on Nivolumab Response in Metastatic Non-Small Cell Lung Cancer: A Multicenter Real-Life StudyEngin Hendem, Mehmet Zahid Koçak, Ayşegül Merç Çetinkaya, et al.
Pageof 27

Showing results (221-230 of 263) with videos related to

Sort By:
Pageof 27
European Radiology|August 20, 2025
Applying large language model for automated quality scoring of radiology requisitions using a standardized criteriaRaşit Eren Büyüktoka, Murat Surucu, Pelin Berfin Erekli Derinkaya, et al.
Molecular and Clinical Oncology|December 2, 2015
Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumabSeyda Gündüz, Sema Sezgin Göksu, Deniz Arslan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 26, 2014
Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging systemDeniz Arslan, Hakan Bozcuk, Seyda Gunduz, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 11, 2018
Adding taxane to platin-5-fluorouracil combination does not improve survival rate in patients ≥ 65 years of age with advanced gastric cancer: A retrospective-multicenter studyMeral Gunaldi, Fatih Kose, Nebi Serkan Demirci, et al.
Future Oncology (London, England)|April 13, 2019
The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetateCem Onal, Ali Murat Sedef, Fatih Kose, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 1, 2019
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetateBerna Akkus Yildirim, Cem Onal, Fatih Kose, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 28, 2014
Risk factors for stage IV breast cancer at the time of presentation in TurkeyUmmugul Uyeturk, Ali Murat Tatli, Sebahat Gucuk, et al.
Medicina (Kaunas, Lithuania)|February 26, 2025
Comparison of Standard Neoadjuvant Therapy and Total Neoadjuvant Therapy in Terms of Effectiveness in Patients Diagnosed with Locally Advanced Rectal CancerAyberk Bayramgil, Ahmet Bilici, Ali Murat Tatlı, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) StudyZiya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Medicina (Kaunas, Lithuania)|January 28, 2026
The Impact of Concurrent Proton Pump Inhibitors on Nivolumab Response in Metastatic Non-Small Cell Lung Cancer: A Multicenter Real-Life StudyEngin Hendem, Mehmet Zahid Koçak, Ayşegül Merç Çetinkaya, et al.
Pageof 27